Reports Q3 revenue $1.2B, consensus $1.64B. “Our focus on execution continues to drive growth, with significant opportunity ahead,” said Brent Saunders, chairman and CEO, Bausch + Lomb (BLCO). “We’re in the middle of multi-dimensional launch cycles around the world, covering all our businesses and targeting all our audiences.”
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLCO:
- Bausch Health price target raised to $10 from $8.50 at RBC Capital
- Bausch + Lomb price target raised to $23 from $20 at RBC Capital
- Banks competing to fund possible Bausch + Lomb buyout, Bloomberg says
- Etsy, Enphase downgraded: Wall Street’s top analyst calls
- Bausch + Lomb upgraded to Outperform from In Line at Evercore ISI